Functions of natural killer cells
The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Abstract
Natural killer (NK) cells are effector lymphocytes of the innate immune system that control several types of tumors and microbial infections by limiting their spread and subsequent tissue damage. Recent research highlights the fact that NK cells are also regulatory cells engaged in reciprocal interactions with dendritic cells, macrophages, T cells and endothelial cells. NK cells can thus limit or exacerbate immune responses. Although NK cells might appear to be redundant in several conditions of immune challenge in humans, NK cell manipulation seems to hold promise in efforts to improve hematopoietic and solid organ transplantation, promote antitumor immunotherapy and control inflammatory and autoimmune disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, myofibroblasts that fail to enter senescence and continue to produce scar tissue are resistant to NK activity and perpetuate fibrosis even after the inflammatory stimulus has reduced.84,85”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [84]
Citations
Cites
The biology of human natural killer-cell subsets
Cooper, M. A., Fehniger, T. A., & Caligiuri, M. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02060-9 · Cited by 2,975 · cited 1×
“In humans, NK cells can be divided into CD56 dim and CD56 bright NK cell subsets, which differ in their homing propertie”
BackgroundBiology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902 · cited 1×
“NK cells were later recognized as a separate lymphocyte lineage, with both cytotoxicity and cytokine-producing effector function”
BackgroundLanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769 · cited 1×
“Activating NK cell receptors detect the presence of ligands on cells in 'distress', such as the stress-induced self ligands recognized by NKG2D (human ULBP and MIC molecules, as well as mouse RAE1, H60 and MULT1 molecules”
BackgroundSelective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H. G., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,161 · cited 1×
“As a consequence, NK cells have been described as able to recognize 'missing self' on hematopoietic cell”
BackgroundNATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., & Salazar-Mather, T. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.189 · Cited by 2,113 · cited 1×
“, whereas chemokines such as CCL3 (MIP-1α), CXCL10 (IP-10) and CXCL9 (MIG) coordinately regulate NK cell traffickin”
BackgroundMiller, J. S., Soignier, Y., Panoskaltsis-Mortari, A., McNearney, S. A., Yun, G. H., Fautsch, S. K., McKenna, D., Le, C., Defor, T. E., Burns, L. J., et al. (2005) · Blood · doi:10.1182/blood-2004-07-2974 · Cited by 1,903 · cited 1×
“, and NK cell–mediated therapy after hematopoietic cell transplantation seems saf”
BackgroundDecidual NK cells regulate key developmental processes at the human fetal-maternal interface
Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D., Cohen-Daniel, L., Arnon, T. I., Manaster, I., et al. (2006) · Nature Medicine · doi:10.1038/nm1452 · Cited by 1,681 · cited 1×
“uNK represent a very distinct subset of NK cells that secrete proangiogenic factors such as vascular endothelial growth factor (VEGF), placental growth factor (PLGF) and NKG5 (ref”
BackgroundInduced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
Martín-Fontecha, A., Thomsen, L. L., Brett, S., Gerard, C., Lipp, M., Lanzavecchia, A., & Sallusto, F. (2004) · Nature Immunology · doi:10.1038/ni1138 · Cited by 1,353
Licensing of natural killer cells by host major histocompatibility complex class I molecules
Kim, S., Poursine-Laurent, J., Truscott, S. M., Lybarger, L., Song, Y.-J., Yang, L., French, A. R., Sunwoo, J. B., Lemieux, S., Hansen, T. H., et al. (2005) · Nature · doi:10.1038/nature03847 · Cited by 1,340 · cited 1×
“This education process requires the recognition of self–MHC class I molecules by cognate inhibitory receptors, such as Ly49 molecules in mice and KIRs in human”
BackgroundDirect Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors
Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B., & Lanier, L. L. (2002) · Science · doi:10.1126/science.1070884 · Cited by 1,230
Research works printed but not linked: 1
- Stewart, C.A. & Vivier, E. Strategies of NK cell recognition and their roles in tumor immunosurveillance. in How the Immune System Recognizes Self and Nonself: Immunoreceptors and Their Signaling (ed. Kitamura, D.) 37–81 (Springer, Tokyo, 2007).
Cited by
Items 901–1,000 of 1,008
Hoffmann, S. C., Cohnen, A., Ludwig, T. E., & Watzl, C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002867 · Cited by 58
“N atural killer cells are important effector cells of the innate immune system and are involved in immune reactions against viral infections and cancer (1).”
BackgroundDifferential activation of cord blood and peripheral blood natural killer cells by cytokines
Alnabhan, R., Madrigal, J. A., & Saudemont, A. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2014.08.003 · Cited by 56
NK cell development and function – Plasticity and redundancy unleashed
Cichocki, F. M., Sitnicka, E., & Bryceson, Y. T. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.02.003 · Cited by 68
The antiviral effects of acteoside and the underlying IFN-γ-inducing action
Song, X., He, J., Xu, H. Y., Hu, X.-P., Wu, X.-L., Wu, H.-Q., Liu, L.-Z., Liao, C.-H., Zeng, Y., Li, Y., et al. (2016) · Food & Function · doi:10.1039/c6fo00335d · Cited by 59
Immunological and Translational Aspects of NK Cell-Based Antitumor Immunotherapies
Shevtsov, M. A., & Multhoff, G. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00492 · Cited by 57
“, NK-92 cells) (14), freshly isolated peripheral blood NK cells (2, 90), or induced pluripotent stem cells (iPSCs) (3) or after subsequent differentiation into mature NK cells (91, 92).”
BackgroundWeil, S., Memmer, S., Lechner, A., Huppert, V., Giannattasio, A., Becker, T., Müller-Runte, A., Lampe, K., Beutner, D., Quaas, A., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00387 · Cited by 54
“NK cells mediate immunosurveillance of malignantly transformed cells (15, 16).”
BackgroundPoznanski, S. M., Lee, A. J., Nham, T., Lusty, E., LARCHÉ, M. J., Lee, D. A., & Ashkar, A. A. (2017) · Journal of Innate Immunity · doi:10.1159/000477172 · Cited by 54
Inflammasomes: Emerging Central Players in Cancer Immunology and Immunotherapy
Karan, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03028 · Cited by 58
“Recent studies showed that NK cells are also regulatory cells engaged in reciprocal interactions with dendritic cells, macrophages, T cells, and endothelial cells (67, 68).”
BackgroundMicroRNA-142 Is Critical for the Homeostasis and Function of Type 1 Innate Lymphoid Cells
Berrien-Elliott, M. M., Sun, Y., Neal, C. C., Ireland, A. R., Trissal, M. C., Sullivan, R. P., Wagner, J. A., Leong, J. W., Wong, P., Mah-Som, A. Y., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.016 · Cited by 54
“NK cells are important for controlling viral infections and eliminating malignant cells (Vivier et al., 2008).”
BackgroundImmune biological rationales for the design of combined radio- and immunotherapies
Hader, M., Frey, B., Fietkau, R., Hecht, M., & Gaipl, U. S. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02460-3 · Cited by 60
“This makes NK cells a good prognostic factor for clinical outcome, especially in the context of recurrences [12, 25, 26].”
BackgroundWhy natural killer cells in triple negative breast cancer?
Abdel-Latif, M., & Youness, R. A. (2020) · World Journal of Clinical Oncology · doi:10.5306/wjco.v11.i7.464 · Cited by 57
Regulatory functions of NK cells during infections and cancer
Zwirner, N. W., Domaica, C. I., & Fuertes, M. B. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0820-685r · Cited by 66
Shannon, J. P., Vrba, S. M., Reynoso, G. V., Wynne-Jones, E., Kamenyeva, O., Malo, C. S., Cherry, C. R., McManus, D. T., & Hickman, H. D. (2021) · Immunity · doi:10.1016/j.immuni.2020.12.004 · Cited by 56
“There is a rich and diverse literature detailing direct NK cell-mediated control of viral infection (Vivier et al., 2008).”
BackgroundRole of Natural Killer Cells during Pregnancy and Related Complications
Mahajan, D., Sharma, N. R., Kancharla, S., Kolli, P., Tripathy, A., Sharma, A. K., Singh, S., Kumar, S., Mohanty, A. K., & Jena, M. K. (2022) · Biomolecules · doi:10.3390/biom12010068 · Cited by 63
“They are the large cytotoxic innate lymphoid cells that regulate leukocyte activation and microbial infection surveillance immunologically [10,11].”
BackgroundBinding mode of the side-by-side two-IgV molecule CD226/DNAM-1 to its ligand CD155/Necl-5
Wang, H., Qi, J., Zhang, S., Li, Y., Tan, S., & Gao, G. F. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815716116 · Cited by 54
“NK cells also help activate and reshape the adaptive immune responses via secreted cytokines (1).”
BackgroundNK cells and Treg cells: A fascinating dance cheek to cheek
Zimmer, J., Andrès, E., & Hentges, F. (2008) · European Journal of Immunology · doi:10.1002/eji.200838813 · Cited by 54
Amyotrophic lateral sclerosis patients show increased peripheral and intrathecal T-cell activation
Rolfes, L., Schulte‐Mecklenbeck, A., Schreiber, S., Vielhaber, S., Herty, M., Marten, A., Pfeuffer, S., Ruck, T., Wiendl, H., Groß, C. C., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab157 · Cited by 58
Natural Killer Cells: From Basic Research to Treatments
Vivier, É., & Ugolini, S. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00018 · Cited by 58
“NK cells are lymphocytes of the innate immune system that can kill an array of target cells and secrete cytokines that participate to the shaping of the adaptive immune response (Vivier et al., 2008, 2011).”
Self-citationInteraction between innate immunity and porcine reproductive and respiratory syndrome virus
Sang, Y., Rowland, R. R. R., & Blecha, F. (2011) · Animal Health Research Reviews · doi:10.1017/s1466252311000144 · Cited by 61
“Granulocytes, macro- phages and NK cells are well documented for their role as effector cells in engulfing and digesting microorganisms or promoting active death of infected cells (Ludwig et al., 2006; Appelberg, 2007; Takeuchi and Akira, 2007; Vivier et al., 2008).”
BackgroundMicroRNA-15/16 Antagonizes Myb To Control NK Cell Maturation
Sullivan, R. P., Leong, J. W., Schneider, S. E., Ireland, A. R., Berrien-Elliott, M. M., Singh, A., Schappe, T., Jewell, B. A., Sexl, V., & Fehniger, T. A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500949 · Cited by 55
Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy
Yin, J., Markert, J. M., & Leavenworth, J. W. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00136 · Cited by 57
“NK cells can sense infected cells either through direct interaction with PAMPs via TLRs or through recognition of viral and/or virus-induced ligands via activating NK cell receptors (35).”
BackgroundInnate lymphoid cells in lung infection and immunity
Stehle, C., Hernández, D. C., & Romagnani, C. (2018) · Immunological Reviews · doi:10.1111/imr.12712 · Cited by 61
Farsakoglu, Y., Palomino‐Segura, M., Latino, I., Zanaga, S., Chatziandreou, N., Pizzagalli, D. U., Rinaldi, A., Bolis, M., Sallusto, F., Stein, J. V., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.104 · Cited by 61
“Involvement of NK Cells in the Early Inflammatory Reaction Initiated by LNMs Considering that NK cells are known to be one of the key players in the type II IFN response (Vivier et al., 2008), we evaluated their production of IFNg following influenza vaccination.”
BackgroundTuminello, S., Veluswamy, R. R., Lieberman‐Cribbin, W., Gnjatic, S., Petralia, F., Wang, P., Flores, R. M., & Taioli, E. (2019) · Oncotarget · doi:10.18632/oncotarget.27392 · Cited by 102
“CD56/57 expressing NK cells, a part of the innate immune system, are capable of quickly recognizing and killing both infected and malignant cells that have lost their MHC I receptors, without priming or prior activation [19].”
BackgroundInnate Lymphocytes in Psoriasis
Polese, B., Zhang, H., Thurairajah, B., & King, I. L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00242 · Cited by 61
Duault, C., Kumar, A., Khani, A. T., Lee, S. J., Yang, L., Huang, M., Hurtz, C., Manning, B. S., Ghoda, L. Y., McDonald, T., et al. (2021) · Blood · doi:10.1182/blood.2020009871 · Cited by 62
Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art
Hatami, Z., Hashemi, Z. S., Eftekhary, M., Amiri, A., Karpisheh, V., Nasrollahi, K., & Jafari, R. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02996-6 · Cited by 54
“They can be further divided into cytotoxic CD56-dim-CD16-bright, which contains 90% of NK cells presented under physiological conditions, and CD56-bright-CD16 + included 10% of NK cells generated interferon-gamma (IFN-γ) [10].”
BackgroundRoberti, M. P., Juliá, E. P., Rocca, Y., Amat, M., Bravo, A., Loza, J., Coló, F. A., Loza, C. M., Fabiano, V. Y., Maino, M., et al. (2015) · European Journal of Immunology · doi:10.1002/eji.201445353 · Cited by 54
Viral load and immune response dynamics in patients with haemorrhagic fever with renal syndrome
Korva, M., Saksida, A., Kejžar, N., Schmaljohn, C. S., & Avšič‐Županc, T. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12218 · Cited by 52
“In addition, NK cells can also influence the adaptive immune response directly by secreting IFN-c [31].”
BackgroundBone specific immunity and its impact on metastasis
Baschuk, N., Rautela, J., & Parker, B. S. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.32 · Cited by 55
“Unlike antigen-specific T cells, NK-mediated elimination of infected, stressed or transformed cells relies upon the sum of activating and inhibitory receptors engaged by ligands on a potential target.(28) Interestingly, NK cells appear to fulfill an important role in ‘missing self’ recognition of cells that manage to…”
BackgroundLópez‐Botet, M., Vilches, C., Redondo‐Pachón, D., Muntasell, A., Pupuleku, A., Yélamos, J., Pascual, J., & Crespo, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00166 · Cited by 56
“Curr Opin Organ Transplant (2015) 20(3):359–67.”
Challenges of NK cell-based immunotherapy in the new era
Fang, F., Xiao, W., & Tian, Z. (2018) · Frontiers of Medicine · doi:10.1007/s11684-018-0653-9 · Cited by 58
Blom, K. G., Cuapio, A., Sandberg, J. T., Varnaitė, R., Michaëlsson, J., Björkström, N. K., Sandberg, J. K., Klingström, J., Lindquist, L., Russ, S. G., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02174 · Cited by 55
“Several activating receptors recognize molecules that are up-regulated on cells during conditions of cellular stress, such as viral infection and transformation [reviewed in (48, 49)] whereas many inhibitory receptors, e.”
BackgroundNatural killer cells in lung transplantation
Calabrese, D. R., Lanier, L. L., & Greenland, J. R. (2018) · Thorax · doi:10.1136/thoraxjnl-2018-212345 · Cited by 59
Immunometabolism: A new target for improving cancer immunotherapy
Guo, C., Chen, S., Liu, W., Ma, Y., Li, J., Fisher, P. B., Fang, X., & Wang, X. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.004 · Cited by 59
Pregnancy-Induced Alterations in NK Cell Phenotype and Function
Gars, M. L., Seiler, C., Kay, A. W., Bayless, N. L., Starosvetsky, E., Moore, L., Shen-Orr, S. S., Aziz, N., Khatri, P., Dekker, C. L., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02469 · Cited by 52
“Together, the activating and inhibitory receptors define the degree of NK cell maturation and responsiveness to stimuli (20, 21).”
BackgroundRps27a might act as a controller of microglia activation in triggering neurodegenerative diseases
Khayer, N., Mirzaie, M., Marashi, S., & Jalessi, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239219 · Cited by 55
Ben‐Shmuel, A., Sabag, B., Biber, G., & Barda‐Saad, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.609532 · Cited by 62
Esen, F., Deniz, G., & Çetin, E. A. (2021) · Immunology Letters · doi:10.1016/j.imlet.2021.09.009 · Cited by 57
Åkesson, C. P., Uvebrant, K., Oderup, C., Lynch, K. F., Harris, R. A., Lernmark, Å., Agardh, C. –., & Cilio, C. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04114.x · Cited by 59
Fully functional NK cells after unrelated cord blood transplantation
Béziat, V., Nguyen, S., Lapusan, S., Hervier, B., Dhédin, N., Bories, D., Uzunov, M., Boudifa, A., Trebeden‐Negre, H., Norol, F., et al. (2009) · Leukemia · doi:10.1038/leu.2008.343 · Cited by 60
Kim, H., & Nam, J. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01551-9 · Cited by 70
“NK cells are essential components of the innate immune system, endowed with the ability to recognize and eliminate tumor cells without prior sensitization, thereby serving as critical mediators of antitumor immunosurveillance 49 .”
Tittarelli, A., Mendoza‐Naranjo, A., Vergara, M. F., Guerrero, I., Ihara, F., Wennerberg, E., Riquelme, S. A., Gleisner, M. A., Kalergis, A. M., Lundqvist, A., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301297 · Cited by 54
“NK cell cytotoxic activity depends upon multiple factors, including the cytokine microenvironment and interactions with other cells of the immune system, such as macrophages, T cells, and DCs (15).”
BackgroundZheng, Q., Zhu, Y., Chen, J., Ye, Y. B., Li, J., Liu, Y., Hu, M., Zheng, Y., & Jiang, J. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12597 · Cited by 53
Virus-mediated inhibition of natural cytotoxicity receptor recognition
Seidel, E., Glasner, A., & Mandelboim, O. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1001-x · Cited by 58
“NK cells are capable of recognizing cells that are transformed or infected with pathogens and kill these cells via the release of cytotoxic granules or through death receptors [2, 4, 5].”
BackgroundMüller, S., Zocher, G., Steinle, A., & Stehle, T. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000723 · Cited by 59
Kim, H. J., Lee, J. S., Kim, A., Koo, S., Cha, H. J., Han, J., Do, Y., Kim, K. M., Kwon, B. S., Mittler, R. S., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300358 · Cited by 52
“Even though NK cells interact with various immune system components (19), our results show that NK cell–parenchymal cell interactions control acute tissue inflammation.”
Modulation of Toll-like receptor signaling in innate immunity by natural products
Chen, L., & Yu, J. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.02.005 · Cited by 57
“A major cytokine secreted by NK cells, IFN-γ is vital in activating both the innate and adaptive immune systems [74].”
BackgroundEomesodermin and T-bet mark developmentally distinct human natural killer cells
Collins, A., Rothman, N. J., Liu, K., & Reiner, S. L. (2017) · JCI Insight · doi:10.1172/jci.insight.90063 · Cited by 54
“NK cells, members of the innate lymphoid cell (ILC) family, play important roles in cytotoxicity and cytokine production (4, 5).”
BackgroundZiblat, A., Núñez, S. Y., Iraolagoitia, X. L. R., Spallanzani, R. G., Torres, N. I., Sierra, J. M., Secchiari, F., Domaica, C. I., Fuertes, M. B., & Zwirner, N. W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01959 · Cited by 52
Modulatory Effects of Pregnancy on Inflammatory Bowel Disease
van der Giessen, J., Huang, V., van der Woude, C. J., & Fuhler, G. M. (2019) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000009 · Cited by 55
“Decidual NK cells may possess both immuneactivating and regulatory properties (59), and although their presence is beneficial during early pregnancy, their persistence or failure to switch to a different phenotype in later pregnancy is associated with adverse pregnancy outcomes (60,61).”
BackgroundChiu, P.-L., Chang, C.-H., Lin, Y., Tsou, P., & Li, B. (2019) · Scientific Reports · doi:10.1038/s41598-019-44677-3 · Cited by 55
Chimeric antigen receptor (CAR)-modified NK cells against cancer: Opportunities and challenges
Wang, L., Dou, M., Ma, Q., Yao, R., & Liu, J. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105695 · Cited by 53
Natural killer cells in the pathogenesis of preeclampsia: a double-edged sword
Du, M., Wang, W., Huang, L., Guan, X., Lin, W. Y., Yao, J., & Li, L. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1740675 · Cited by 52
Bouchaud, G., Garrigue‐Antar, L., Solé-Jamault, V., Quéméner, A., Boublik, Y., Mortier, E., Perdreau‐Dahl, H., Jacques, Y., & Plet, A. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.07.019 · Cited by 51
Cancer immunotherapy μ-environment LabChip: taking advantage of optoelectronic tweezers
Ke, L.-Y., Kuo, Z.-K., Chen, Y.-S., Yeh, T.-Y., Dong, M., Tseng, H.-W., & Liu, C.-H. (2018) · Lab on a Chip · doi:10.1039/c7lc00963a · Cited by 50
Martínez-Espinosa, I., Serrato, J. A., & Ortíz-Quintero, B. (2021) · Biomolecules · doi:10.3390/biom12010004 · Cited by 60
“The conventional effector functions of NK cells include their cytotoxic activity and the production of pro-inflammatory cytokines, such as interferon gamma (IFNγ), which induce a potent inflammatory response [2].”
BackgroundNatural Killer Cell-Mediated Immunotherapy for Leukemia
Allison, M., Mathews, J., Gilliland, T. M., & Mathew, S. O. (2022) · Cancers · doi:10.3390/cancers14030843 · Cited by 57
“Expressed on the surface of each NK cell is an abundant assortment of activating, inhibitory and cytokine receptors that interact with their specific ligands expressed on the surfaces of other cells including immune cells, host tissues and foreign invaders [57,58].”
BackgroundFoltz, J. A., Tran, J., Wong, P., Fan, C., Schmidt, E., Fisk, B. A., Becker‐Hapak, M., Russler‐Germain, D. A., Johnson, J., Marín, N. D., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adk4893 · Cited by 62
Deng, Y., Chu, J., Ren, Y., Fan, Z., Ji, X., Mundy-Bosse, B. L., Yuan, S., Hughes, T. L., Zhang, J., Cheema, B. S., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302600 · Cited by 56
“granular lymphocytes with both cytotoxicity and cytokineproducing effector functions, representing one of major sources of IFN-g in our bodies (2).”
BackgroundTumor-Primed NK Cells: Waiting for the Green Light
Sabry, M., & Lowdell, M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00408 · Cited by 45
“Besides exhibiting cytotoxicity against a variety of “stressed” cells, NK cells also secrete a milieu of cytokines that participate in shaping adaptive immune responses (5).”
BackgroundTissue-specific NK cell populations and their origin
Lysakova-Devine, T., & O’Farrelly, C. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.1ru0514-241r · Cited by 54
“[1]).”
MICA SNPs and the NKG2D system in virus-induced HCC
Goto, K., & Kato, N. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-1000-9 · Cited by 53
Andersson, A. K., Sumariwalla, P. F., McCann, F. E., Amjadi, P., Chang, C., McNamee, K., Tornehave, D., Haase, C., Agersø, H., Stennicke, V. W., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30460 · Cited by 49
Immune response to bovine viral diarrhea virus—looking at newly defined targets
Chase, C. C. L., Thakur, N., Darweesh, M. F., Morarie, S. E., & Rajput, M. (2015) · Animal Health Research Reviews · doi:10.1017/s1466252315000110 · Cited by 60
The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment
Vries, N. L. D., Swets, M., Vahrmeijer, A. L., Hokland, M., & Kuppen, P. J. K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071030 · Cited by 52
Diversification of human NK cells: Lessons from deep profiling
Wilk, A. J., & Blish, C. A. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.6ri0917-390r · Cited by 54
Bosi, A., Zanellato, S., Bassani, B., Albini, A., Musco, A., Cattoni, M., Desio, M., Nardecchia, E., D’Urso, D. G., Imperatori, A. S., et al. (2018) · Journal of Immunology Research · doi:10.1155/2018/2438598 · Cited by 52
“Natural killer (NK) cells are lymphoid cells of the innate immune system included in the recent redefined family of innate lymphoid cells (ILC) as type 1 ILC [1, 2] and represent about 10–20% of total lymphocytes in human peripheral blood (PB) [3].”
Wang, Y., Tian, M., Wang, F., Heng, B. C., Zhou, J., Cai, Z., & Liu, H. (2019) · Stem Cells and Development · doi:10.1089/scd.2018.0256 · Cited by 55
“In the context of allotransplantation, NK cells can respond to the allografts by recognizing ‘‘missing self’’ MHC-I molecules [40].”
Kim, B. J., Jeong, H., Park, S., & Lee, S. J. (2015) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2015.06.004 · Cited by 57
Gui, Q., Wang, A., Zhao, X., Huang, S., Tan, Z., Xiao, C., & Yang, Y. (2020) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-0670-z · Cited by 49
Liu, W. N., So, W. Y., Harden, S. L., Fong, S. Y., Wong, M. X. Y., Tan, W. W. S., Tan, S. Y., Ong, J. K. L., Rajarethinam, R., Liu, M., et al. (2022) · Science Advances · doi:10.1126/sciadv.add1187 · Cited by 53
“Natural killer (NK) cells are capable of killing tumor cells directly by releasing granzyme and perforin or producing interferon- (IFN- ) to mount an adaptive immune response ( 12 , 13 ).”
Ben‐Shmuel, A., Gruper, Y., Halperin, C., Levi-Galibov, O., Rosenberg-Fogler, H., Barki, D., Carradori, G., Stein, Y., Yagel, G., Naumova, M., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0131 · Cited by 63
Luci, C., Gaudy‐Marqueste, C., Rouzaire, P., Audonnet, S., Cognet, C., Hennino, A., Nicolas, J., Grob, J., & Tomasello, E. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10814.x · Cited by 49
Self-citationVogler, I., & Steinle, A. (2011) · Journal of Innate Immunity · doi:10.1159/000324112 · Cited by 52
“Natural killer (NK) cells are lymphocytes of the innate immune system capable of destroying aberrant and potentially harmful cells such as malignant or virus-infected cells [ ,”
BackgroundAvau, A., Put, K., Wouters, C. H., & Matthys, P. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.05.005 · Cited by 53
“In mice, three NK subsets can be defined via expression of CD11b and CD27, with CD11bCD27 NK cells corresponding to CD56 human NK cells based on phenotype and anatomical localization [71].”
BackgroundQiu, F., Maniar, A., Quevedo-Díaz, M., Chapoval, A. I., & Medvedev, A. E. (2010) · Innate Immunity · doi:10.1177/1753425910372000 · Cited by 58
Müller, L. L., Meyer, M., Bauer, R. N., Zhou, H., Zhang, H., Jones, S., Robinette, C., Noah, T. L., & Jaspers, I. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147742 · Cited by 49
“To distinguish self from non-self, NK cells also express inhibitory receptors, such as CD158b/KIR2/3D and CD159a/NKG2A, which recognize human leukocyte antigen and ensure that autologous cells are only eliminated if showing strong abnormalities or signs of infection [16].”
BackgroundInfluentialImproving natural killer cell cancer immunotherapy
Berrien-Elliott, M. M., Romee, R., & Fehniger, T. A. (2015) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000243 · Cited by 53
Hepatitis B virus antigens impair NK cell function
Yang, Y., Han, Q., Zhang, C., Xiao, M., & Zhang, J. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.06.015 · Cited by 49
Liyanage, S. E., Gardner, P. J., Ribeiro, J., Cristante, E., Sampson, R. D., Luhmann, U. F. O., Ali, R. R., & Bainbridge, J. W. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.08.007 · Cited by 46
Nieto-Velázquez, N. G., Torres-Ramos, Y. D., Muñoz-Sánchez, J. L., Espinosa-Godoy, L., Gómez-Cortés, S., Moreno, J. G., & Moreno‐Eutímio, M. A. (2016) · Translational Oncology · doi:10.1016/j.tranon.2016.07.003 · Cited by 54
Dobbs, K., Tabellini, G., Calzoni, E., Patrizi, O., Martínez, P., Giliani, S. C., Moratto, D., Al–Herz, W., Cancrini, C., Cowan, M. J., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00798 · Cited by 49
“Cell Death Differ (2008) 15(2):226–33.”
BackgroundInfluentialPallmer, K., Barnstorf, I., Baumann, N. S., Borsa, M., Jonjić, S., & Oxenius, A. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007725 · Cited by 53
Pekar, L., Klausz, K., Busch, M., Valldorf, B., Kolmar, H., Wesch, D., Oberg, H., Krohn, S., Boje, A. S., Gehlert, C. L., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2001004 · Cited by 51
“self–MHC class I on tissues and either killer Ig-like receptor (KIR) family members or NK group 2A (NKG2A) (2).”
BackgroundEller, M. A., Eller, L. A., Ouma, B. J., Thelian, D., Gonzalez, V. D., Guwatudde, D., McCutchan, F. E., Marovich, M., Michael, N. L., de Souza, M. S., et al. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181aa256e · Cited by 49
“Natural killer (NK) cells are innate immune effector cells that play important roles in the control of certain types of tumors and microbial infections through cytotoxicity without prior sensitization, regulation of immune responses through cytokine, and chemokine production, as well as ‘‘cross talk’’ with antigen-pre…”
BackgroundChoi, H., Lee, N., & Paik, H. (2015) · Food Science and Biotechnology · doi:10.1007/s10068-015-0102-3 · Cited by 51
“role in controlling certain types of tumors and infections, since they have natural cytotoxic activity (14).”
BackgroundGuo, X., Mahlakõiv, T., Ye, Q., Somanchi, S. S., He, S., Rana, H., DiFiglia, A., Gleason, J., van der Touw, W., HARIRI, R. J., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001975 · Cited by 54
Natural killer cells suppress cancer metastasis by eliminating circulating cancer cells
Vyas, M., Requesens, M., Nguyen, T. H., Peigney, D., Azin, M., & Demehri, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1098445 · Cited by 52
“NK cell activation is regulated by a variety of germline-encoded activating and inhibitory receptors to prevent the non-specific destruction of normal tissue while enabling the clearance of target cells (8).”
BackgroundNatural Killer Cell-Based Immunotherapy against Glioblastoma
Morimoto, T., Nakazawa, T., Maeoka, R., Nakagawa, I., Tsujimura, T., & Matsuda, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032111 · Cited by 54
Tissue‐specific effector functions of innate lymphoid cells
Björkström, N. K., Kekäläinen, E., & Mjösberg, J. (2013) · Immunology · doi:10.1111/imm.12098 · Cited by 58
Inflammasomes and Anti-Viral Immunity
Rathinam, V. A. K., & Fitzgerald, K. A. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9431-4 · Cited by 53
“NK cells contribute to early anti-viral defenses by exerting antiviral effects through the secretion of interferon (IFN)-γ and by elimination of virusinfected cells [ 1 ].”
BackgroundProNGF mediates death of Natural Killer cells through activation of the p75NTR–sortilin complex
Rogers, M., Bailey, S., Matusica, D., Nicholson, I., Muyderman, H., Pagadala, P., Neet, K., Zola, H., Macardle, P. J., & Rush, R. A. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.040 · Cited by 60
“Tumor necrosis factor receptor super family (TNFRSF) ligands are crucial to Natural Killer (NK) cell development, ability to kill and their cross talk to other immune cells (Kashii et al., 1999; Vivier et al., 2008; Zingoni et al., 2004).”
A novel Artificial Immune System for fault behavior detection
Laurentys, C. A., Palhares, R. M., & Caminhas, W. M. (2010) · Expert Systems with Applications · doi:10.1016/j.eswa.2010.12.019 · Cited by 48
CD8+ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activity
Pluhar, G. E., Pennell, C. A., & Olin, M. R. (2015) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2015013607 · Cited by 56
Lunemann, S., Martrus, G., Hölzemer, A., Chapel, A., Ziegler, M. C., Körner, C., García-Beltrán, W. F., Carrington, M. N., Wedemeyer, H. H., & Altfeld, M. A. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.03.016 · Cited by 51
“The main NK cell function is the elimination of target cells by directed release of perforin and granzyme, or engagement of apoptosis-inducing receptors such as FAS [2].”
BackgroundPantic, J. M., Jovanović, I., Radosavljevic, G. D., Arsenijević, N., Conlon, J. M., & Lukić, M. L. (2017) · Molecules · doi:10.3390/molecules22122071 · Cited by 49
“NK cells are crucial participants in the protection against infections and tumours mainly as a result of their powerful cytolytic machinery [67,68].”
BackgroundBioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy
Assal, R. E., Abou‐Elkacem, L., Tocchio, A., Pasley, S., Matosevic, S., Kaplan, D. L., Zylberberg, C., & Demirci, U. (2019) · Advanced Science · doi:10.1002/advs.201802045 · Cited by 48
Moon, W. Y., & Powis, S. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01703 · Cited by 52
“NK cells have activating and inhibitory receptors (1) which allow NK cells to selectively target pathogenic cells while preventing autoimmunity against autologous cell (2).”
BackgroundWu, X., & Huang, S. (2019) · Bulletin du Cancer · doi:10.1016/j.bulcan.2019.03.012 · Cited by 49
Metadata
- Authors
- Vivier, E., Tomasello, E., Baratin, M., Walzer, T., & Ugolini, S.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Venue
- Nature Immunology
- Published
- 2008-04-18
- Volume
- 9
- Issue
- 5
- Pages
- 503-510
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2073300038
- Cited by
- 3,943
- References
- 109
- Citations by year
- 2026: 195 · 2025: 269 · 2024: 299 · 2023: 292 · 2022: 302 · 2021: 332 · 2020: 260 · 2019: 271 · 2018: 224 · 2017: 247 · 2016: 202 · 2015: 195 · 2014: 159 · 2013: 156 · 2012: 141
- FWCI
- 9.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- European Commission
- Agence Nationale de la Recherche
- Institut National de la Santé et de la Recherche Médicale
- Ministère de l'Enseignement Supérieur et de la Recherche
- Centre National de la Recherche Scientifique
- Institut Universitaire de France
- Institut National Du Cancer
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- natural killer cells, innate immunity, tumor control, microbial infection, regulatory function, dendritic cells, macrophages, T cells, endothelial cells, immune regulation, hematopoietic stem cell transplantation, solid organ transplantation, cancer immunotherapy, inflammation, autoimmune disease
- MeSH terms
- Animals, Autoimmune Diseases, Dendritic Cells, Host vs Graft Reaction, Humans, Immune Tolerance, Inflammation, Killer Cells, Natural, Macrophages, Neoplasms, T-Lymphocytes, Virus Diseases, Immunotherapy, Adoptive, Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.